what does sparc stand for

SPARC stands for Sun Pharma Advanced Research Company Limited, a pharmaceutical R&D company listed on BSE and NSE.

what does sparco stand for

SPARCO is not a recognized term related to Sun Pharma; it may be a misspelling or unrelated acronym.

what does sparc ai do

SPARC AI is not a term associated with Sun Pharma; it might refer to artificial intelligence in general or other contexts.

what does sparc mac look like

SPARC MAC is not a standard term; it could be confused with unrelated acronyms like Macintosh or other unrelated concepts.

what does sparc stand for springfield il

SPARC does not stand for Springfield, IL; it is specific to Sun Pharma's company name.

Sun Pharma Advanced Research Company Limited (SPARC) Share Price Today — ₹205.8

Sun Pharma Advanced Research Company Limited (SPARC) live stock price is ₹205.8. Listed on BSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Sun Pharma Advanced Research Company Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Sun Pharma Advanced Research Company Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

SPARC

BSE

Sun Pharma Advanced Research Company Limited

Healthcare· Pharmaceuticals & Biotechnology· INE232I01014· Scrip: 532872

EN हिन्दी ગુજરાતી मराठी

₹205.80

▲ 3.50 (+0.00%)

2026-06-10

BSE

₹205.80

▲ 3.50

+0.00%

233 trading days · 1Y period

TODAY (BSE)

Open210.00

High214.85

Low204.15

Prev Close209.30

Volume1.78L

Value₹3.7Cr

L: 204.15H: 214.85

Info

Face Value₹1

Listed2007-07-18

ISININE232I01014

SeriesB

BSE Scrip532872

Key Metrics

1D

—

1W

—

1M

—

3M

—

6M

—

Valuation

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales—

Mkt Cap—

Growth (QoQ)

Revenue+15.94%

PAT+25.92%

EPS+25.98%

Profitability

EBITDA Margin-492.5%

Net Margin-533.3%

TTM EBITDA M.-607.3%

TTM Net M.-637.0%

Dividend

Yield—

Latest DPS—

Payout Ratio—

Growth—

TTM Revenue

₹61 Cr

TTM EBITDA

₹-371 Cr

TTM PAT

₹-389 Cr

TTM EPS

₹-12.00

Rev/Share

₹1.9

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	15 Cr	95 Cr	-73 Cr	-79 Cr	-80 Cr	₹-2.45
2024-09-30	13 Cr	120 Cr	-103 Cr	-107 Cr	-107 Cr	₹-3.31
2024-06-30	17 Cr	115 Cr	-94 Cr	-97 Cr	-97 Cr	₹-2.98
2024-03-31	17 Cr	126 Cr	-101 Cr	-105 Cr	-106 Cr	₹-3.26
2023-12-31	14 Cr	120 Cr	-96 Cr	-100 Cr	-100 Cr	₹-3.07
2023-09-30	21 Cr	116 Cr	-83 Cr	-86 Cr	-86 Cr	₹-2.66
2023-03-31	48 Cr	140 Cr	-79 Cr	-82 Cr	-82 Cr	₹-2.55
2022-12-31	131 Cr	121 Cr	16 Cr	10 Cr	10 Cr	₹0.37

Shareholding Pattern

CURRENT — 2026-03-31

Promoter65.7%

FII2.0%

DII0.9%

Public34.3%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2021-09-21	Other	Annual General Meeting
2020-09-22	Other	Annual General Meeting
2019-07-18	Other	Annual General Meeting
2018-07-19	Other	Annual General Meeting
2017-07-27	Other	Annual General Meeting
2017-05-25	Other	Extraordinary General Meeting
2016-07-21	Other	Annual General Meeting
2016-03-16	Rights	Rights 5: 116 At Premium Rs 244/- Per Share
2015-07-23	Other	Annual General Meeting
2014-07-24	Other	Annual General Meeting
2013-07-24	Other	Annual General Meeting
2012-08-23	Rights	Rights 1: 7@ Premium Rs 66 Per Share
2011-07-28	Other	Annual General Meeting
2010-07-16	Other	Annual General Meeting
2009-08-21	Other	Annual General Meeting
2008-08-25	Other	Annual General Meeting
2007-08-28	Other	Agm

Earnings Transcripts

Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation

7 Jan 2024NSE23K chars

Read →

Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation

6 Jan 2024NSE10K chars

Read →

Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation

2 Nov 2023NSE39K chars

Read →

Sun Pharma Advanced Research Company Limited has informed the Exchange about Transcript of Investor ...

28 Oct 2022NSE78K chars

Read →

Sun Pharma Advanced Research Company Limited has informed the Exchange about Recording of Audio Play...

17 Oct 2022NSE1K chars

Read →

Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation

13 Oct 2022NSE31K chars

Read →

Price History

Date	Open	High	Low	Close	Volume
2026-06-10	210.26	214.80	204.20	205.92	20.81L
2026-06-03	205.67	210.59	196.50	208.50	48.49L
2026-05-27	232.16	233.50	213.01	221.35	1.09Cr
2026-05-26	237.00	248.75	231.00	235.57	3.74Cr
2026-05-25	214.00	239.40	212.00	232.99	6.07Cr
2026-05-22	182.00	214.00	179.82	209.77	3.23Cr
2026-05-21	185.00	189.29	179.20	180.33	43.57L
2026-05-20	178.97	185.30	178.00	183.68	88.62L
2026-05-19	174.00	189.45	162.36	179.77	4.31Cr
2026-05-18	162.55	163.88	158.21	162.23	13.34L
2026-05-15	170.75	172.19	162.56	163.65	12.00L
2026-05-14	169.90	172.50	165.40	170.08	15.03L
2026-05-13	166.73	175.60	165.00	168.68	30.24L
2026-05-12	167.00	172.79	162.01	166.43	26.75L
2026-05-11	172.05	172.79	167.00	168.45	22.26L
2026-05-08	167.20	182.59	167.00	173.09	87.39L
2026-05-07	158.50	168.80	155.37	166.85	72.34L
2026-05-06	141.05	161.80	139.60	157.08	2.17Cr
2026-05-05	139.95	145.01	139.32	140.00	31.60L
2026-05-04	144.85	145.01	138.92	139.70	25.13L
2026-04-30	148.56	163.20	141.51	143.04	91.48L
2026-04-29	147.50	149.79	146.05	148.56	14.37L
2026-04-28	146.73	148.60	145.50	146.85	13.15L
2026-04-27	139.91	151.88	139.90	146.72	35.36L
2026-04-24	143.30	143.72	136.72	139.28	6.06L
2026-04-23	143.82	146.90	142.33	142.88	8.32L
2026-04-22	144.35	146.00	143.00	143.54	4.39L
2026-04-21	145.00	147.00	143.60	144.05	5.24L
2026-04-20	148.00	148.45	144.03	144.50	5.69L
2026-04-17	153.11	153.69	147.05	148.01	10.99L

Frequently Asked Questions

About

Sun Pharma Advanced Research Company Limited, formerly known as Sun Pharmaceutical Industries Limited, is an Indian multinational pharmaceutical company focused on research-based drug development. It operates across various therapeutic areas and offers a diverse portfolio of products including generic medicines, specialty pharmaceuticals, and animal health products. The company was established in 2006 and is listed on both the Bombay Stock Exchange and the National Stock Exchange under the symbol SPARC.

BOARD OF DIRECTORS

Vidhi Dilip Shanghvi

Independent Director

Dilip Shanghvi

Director

Rekha Warriar